My memory is only faint also. I want to say it's (at least some of) the leukemias. Having a small # of CD8+ cells from the graft can help kill cancer cells. I also want to say that they don't fully kill the bone marrow in the host before the transplant, as that's supposed to help. The details of which cancers and how to treat them with GVH are probably Step 2 stuff at best.
Aye, the graft vs. host effect is beneficial for the leukemias/lymphomas because the donor T cells help fight the malignant blood cells remaining in the recipient. So in this case, it's more appropriately termed "graft vs. leukemia" effect.
Aye, the graft vs. host effect is beneficial for the leukemias/lymphomas because the donor T cells help fight the malignant blood cells remaining in the recipient. So in this case, it's more appropriately termed "graft vs. leukemia" effect.
Aye, the graft vs. host effect is beneficial for the leukemias/lymphomas because the donor T cells help fight the malignant blood cells remaining in the recipient. So in this case, it's more appropriately termed "graft vs. leukemia" effect.
Aye, the graft vs. host effect is beneficial for the leukemias/lymphomas because the donor T cells help fight the malignant blood cells remaining in the recipient. So in this case, it's more appropriately termed "graft vs. leukemia" effect.
Plus, the lungs would not be heavily involved in graft-versus-host since it doesn't have significant population of the immune cells or lymphoid tissue. I mean there are type II penumocytes but that's really about it.
For BM, and ileum (peyer's patches) it makes much more sense.